Nonalcoholic fatty liver disease in obese and nonobese pediatric patients
Eun Jeong Kim (Kim EJ), Hyun Jin Kim (Kim HJ)
Clin Exp Pediatr. 2019;62(1):30-35.   Published online 2018 Sep 17     DOI:
Citations to this article as recorded by Crossref logo
Diet, exercise, and supplements: what is their role in the management of the metabolic dysfunction-associated steatotic liver disease in children?
Anastasios Serbis, Stergios A. Polyzos, Stavroula A. Paschou, Ekaterini Siomou, Dimitrios N. Kiortsis
Endocrine.2024;[Epub]     CrossRef
Non-alcoholic fatty liver disease: relation to juvenile obesity, lipid profile, and hepatic enzymes
Raghid Reyadh Altalebi, Hany Akeel Al-hussaniy, Zahraa Salam Al-tameemi, Mohammed Abdul-Hassan AL-Zobaidy, Ali Hikmat Albu-Rghaif, Hayder Mutter Alkuraishy, Gomaa Mostafa Hedeab, Faizul Azam, Ali Mahmoud Al-Samydai, Meena Akeel Naji
Journal of Medicine and Life.2023; 16(1): 42.     CrossRef
Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement
Mohammed Eslam, Naim Alkhouri, Pietro Vajro, Ulrich Baumann, Ram Weiss, Piotr Socha, Claude Marcus, Way Seah Lee, Deirdre Kelly, Gilda Porta, Mohamed A El-Guindi, Anna Alisi, Jake P Mann, Nezha Mouane, Louise A Baur, Anil Dhawan, Jacob George
The Lancet Gastroenterology & Hepatology.2021; 6(10): 864.     CrossRef
Validation of a Non-Laboratory Based Screening Tool for Predicting Non-Alcoholic Fatty Liver Disease in an Egyptian Setting
Ekram W. Abd El-Wahab, Rehab A. Zein El-Abedin, Walid M. Ahmed, Hanan Z. Shatat
The American Journal of the Medical Sciences.2020; 360(6): 662.     CrossRef
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Stergios A. Polyzos, Jannis Kountouras, Christos S. Mantzoros
Metabolism.2019; 92: 82.     CrossRef